Mesa Laboratories Inc (MLAB)
Return on equity (ROE)
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -1,974 | -249,443 | -245,651 | -250,309 | -254,246 | 948 | -717 | 1,819 | 930 | -1,465 | -3,976 | -1,562 | 1,871 | 7,575 | 5,093 | 4,052 | 3,082 | -2,518 | -2,606 | -2,223 |
| Total stockholders’ equity | US$ in thousands | — | 155,214 | 161,451 | 150,727 | 145,393 | 402,961 | 387,759 | 387,719 | 393,480 | 387,205 | 374,236 | 380,431 | 393,801 | 396,329 | 399,417 | 399,003 | 406,227 | 412,795 | 392,412 | 382,234 |
| ROE | — | -160.71% | -152.15% | -166.07% | -174.87% | 0.24% | -0.18% | 0.47% | 0.24% | -0.38% | -1.06% | -0.41% | 0.48% | 1.91% | 1.28% | 1.02% | 0.76% | -0.61% | -0.66% | -0.58% |
March 31, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-1,974K ÷ $—K
= —
Mesa Laboratories Inc's return on equity (ROE) has fluctuated significantly over the past few years based on the provided data.
From June 30, 2020, to June 30, 2022, the ROE remained relatively low and even negative, indicating that the company was not efficiently utilizing its shareholders' equity to generate profits during this period.
However, there was a notable improvement in ROE in the subsequent quarters from March 31, 2021, to December 31, 2023, where the ROE turned positive, reaching its peak at 1.91% on December 31, 2021. This period suggests that Mesa Laboratories Inc was able to enhance its profitability relative to the equity invested by shareholders.
The trend reversed in the following quarters from March 31, 2024, to December 31, 2024, with the ROE turning highly negative, indicating a significant decline in profitability compared to the equity base.
The latest data point is missing for March 31, 2025. Based on the historical data, it is evident that the company experienced significant fluctuations in ROE, signifying potential challenges in sustaining consistent profitability relative to its equity base.
Overall, Mesa Laboratories Inc's ROE has shown a mix of both positive and negative trends, reflecting varying levels of efficiency in generating profits from shareholders' equity over the analyzed period.
Peer comparison
Mar 31, 2025